This activity is supported by an independent medical education grant from Carl Zeiss Meditec and Regeneron Pharmaceuticals, Inc.
Upon completion of this activity, the participant should be able to:
Sponsored by:
Evolve is an approved COPE Administrator.
This course is COPE approved for 0.5 hours of CE credit for optometrists.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Andrew A. Moshfeghi, MD, MBA (Program Chair)
Associate Professor of Clinical Ophthalmology
Medical Director of the USC Roski Eye Institute
Director of Clinical Trials
Director of the Vitreoretinal Surgery Fellowship Program
Director of the Medical Retina Fellowship Program
Los Angeles, CA
Group Leaders
Dilsher Dhoot, MD
California Retina Consultants/Retina Consultants of America
Santa Barbara, CA
David Eichenbaum, MD
Clinical Assistant Professor
Department of Ophthalmology
University of South Florida College of Medicine
Retina Vitreous Associates of Florida
Tampa, FL
Avni P. Finn, MD
Vitreoretinal Surgeon
Northern California Retina Vitreous Associates
Mountain View, CA
Roger A. Goldberg, MD, MBA
Partner, Bay Area Retina Associates
Faculty, CPMC Ophthalmology Residency
San Francisco Bay Area, CA
Esther Lee Kim, MD
Vitreoretinal Surgeon Orange County Retina
Santa Ana, CA
Lisa C. Olmos de Koo, MD, MBA
Associate Professor of Ophthalmology
Subspecialty Chief, Retina Division
Program Director, Vitreoretinal Surgery Fellowship
Department of Ophthalmology
University of Washington
Seattle, WA
Sonia Mehta, MD
Assistant Professor of Ophthalmology
Thomas Jefferson University School of Medicine
Philadelphia, PA
Ehsan Rahimy, MD
Vitreoretinal Disease & Surgery
Palo Alto Medical Foundation
Palo Alto, CA
Adrienne W. Scott, MD
Associate Professor of Ophthalmology
Retina Division
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, MD
Jayanth Sridhar, MD
Department of Ophthalmology
Bascom Palmer Eye Institute
Miami, FL
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Andrew Moshfeghi, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Genentech, Graybug, Novartis, Ocular Therapeutix, Pr3vent and Regeneron. Grant/Research Support: Genentech, Novartis, and Regeneron. Stock/Shareholder: Ocular Therapeutix, Pr3vent, and Placid.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Carl Zeiss Meditec or Regeneron Pharmaceuticals, Inc.
